Fresh Tracks Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis
Fresh Tracks Therapeutics, Inc. scores 1/10 on the AskCyborg Cyborg Score (Challenged). Company is no longer operational; historical investment value has been extinguished. The company filed for dissolution in February 2025 after losing Nasdaq listing status in December 2023. No meaningful operations exist as of today's date (June 2026).
What is Fresh Tracks Therapeutics, Inc.'s industry? Fresh Tracks Therapeutics, Inc. (freshtrackstherapeutics.com) operates in Pharmaceuticals. AskCyborg classifies Fresh Tracks Therapeutics, Inc. under Pharmaceuticals in its company registry.
Fresh Tracks Therapeutics was a clinical-stage pharmaceutical company focused on developing therapeutics for autoimmune, inflammatory, and debilitating diseases. The company was dissolved in February 2025, following a...
Cyborg Score thesis
Company is no longer operational; historical investment value has been extinguished....
Read the full analyst-debate transcript →Get the Latest Fresh Tracks Therapeutics, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeFresh Tracks Therapeutics, Inc. Overview
Pro stress-test →Fresh Tracks Therapeutics was a clinical-stage pharmaceutical company focused on developing therapeutics for autoimmune, inflammatory, and debilitating diseases. The company was dissolved in February 2025, following a delisting from Nasdaq in December 2023 and subsequent trading on the OTC Pink market.
Strategic Profile
Pro stress-test →The company was formerly known as Brickell Biotech, Inc. and rebranded in September 2022. Prior to dissolution, it aimed to leverage experienced leadership with track records in commercializing first-in-class pharmaceutical products.
Competitive Landscape
Pro stress-test →N/A - Company is dissolved
Industry Context
Fresh Tracks Therapeutics, Inc. operates in Pharmaceuticals.
Key facts
Founded: 1987 · Headquarters: Boulder, US · Employees: N/A · Revenue: N/A · Market cap: N/A